Advertisement

Topics

Companies Related to "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization" [Most Relevant Company Matches] - Page: 2 RSS

11:07 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization" found in our extensive corporate database of over 50,000 company records.

Showing "NASPI Acetylcysteine Ascorbic Acid Prevention Contrast Induced Nephropathy" Companies 26–50 of 1,000+

Relevant

Gout & Uric Acid Education Society

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and healthcare providers. For more information about gout and the Gout & Uric Acid Education Society, please visit www.gouteducation.org. Gout Awareness Day is sponsored by Ardea Biosciences, Inc., EnzymeRx, LLC., No...


Algenist

A team of biotechnology scientists in San Francisco, California, focused on developing microalgae-based renewable energy solutions, unexpectedly discovered Alguronic Acid, a powerful compound responsible for regenerating and protecting the microalgae cell. When scientifically tested, Alguronic Acid demonstrated significant anti-aging properties, increasing...

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewar...


EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...

Heron Therapeutics, Inc.

Heron Therapeutics is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that nee...

International Contrast Ultrasound Society (ICUS)

Cruachem Limited

Cruachem Ltd, an Annovis Inc. company, is a leader in nucleic acid chemistry. Cruachem offers the largest range of DNA and RNA custom oligonucleotides available including oligomimetics (-molecular mimics used in antisense therapies), as well as DNA and RNA synthesis reagents and molecular biology kits. Our custom oligonucleotides are synthesised using our own high quality phosphoramidites manufac...

Gentra Systems Incorporated

VisionTo shape the future of clinical nucleic acid purification. MissionGentra is committed to leading the field of nucleic acid purification by developing products that improve the speed, ease-of-use, and quality of sample preparation for clinical and high-throughput research applications.

Efamol ltd

Efamol specialises in essential fatty acid (EFAs) based products, the so called "good fats" that are essential for the healthy functioning of every cell in the human body. These "good fats" are from the Omega-3 and Omega-6 families of nutrients and are sourced from high quality fish oils and evening primrose oil. Since it's inception Efamol has developed a specialised range of fatty acid based pro...

Vector Laboratories Incorporated

Vestor have developed new and improved ways of labeling nucleic acid probes. Photoprobe® Biotin is used to randomly label any nucleic acid with biotin. The FastTag® labeling system allows nucleic acid to be easily and econom-ically labeled with any marker. The 5’ EndTag™ system provides a simple method to label only the 5’ hydroxyl groups of DNA or RNA probes.Over the years Vector have int...

Galera Therapeutics, Inc.

Galera Therapeutics, Inc. is a clinical-stage biotechnology company, headquartered in Malvern, PA, focused on the development of breakthrough drugs targeting oxygen metabolic pathways. The Company's lead compounds are highly selective small molecule dismutase mimetics that closely mimic the activity of the human superoxide dismutase enzymes. While the biol...

Howard Leight

Under the Howard Leight brand, Honeywell Safety Products is a leading global provider of passive and intelligent hearing protection solutions, and is the founder of the HearForever™ initiative. For over 30 years, the company and its predecessors have pursued the prevention of occupational noise-induced hearing loss through innovation in hearing protec...

Bioamber

Bioamber is a white biotechnology company dedicated to the development and commercialization of bio-based succinic acid. Bioamber's mission is to license turn-key technology packages to companies seeking to produce succinic acid and its derivatives from renewable feedstocks. Bioamber is a joint venture between DNP Green Technology and Agro-Industrie Recherches et Développements.

A.P. Pharma, Inc.

A.P. Pharma is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery technology. The Company's primary focus is on its lead product, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV). A.P. Pharma submitted a New Drug Application (NDA) to the FDA in May 2009 an...

Immunomic Therapeutics, Inc. and ZENOAQ

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. ITI has entered into a significant licensing agreement with ...

RSR Corporation

RSR Corporation is a privately held secondary lead smelting company that operates lead acid battery recycling facilities in California, Indiana, and New York. RSR uses state-of-the-art Wet Electrostatic Precipitator (WESP) technology and a highly trained workforce to ensure the lead acid batteries we recycle into refined lead do not harm the environment, e...

Yale-Griffin Prevention Research Center

The Yale-Griffin Prevention Research Center (PRC) was established in 1998 through funding from the Centers for Disease Control (CDC). One of 35 such centers nationwide representing academic/community partnerships, the Yale-Griffin PRC is engaged in interdisciplinary applied prevention research in collaboration with community partners, federal, state, and local health and education agencies, and ot...

Probably Relevant

Guerbet LLC

Since 1901 Guerbet Group has had a long-standing tradition as a pioneer in the research and development of medical imaging contrast media. Headquartered in Paris, France, Guerbet is a publicly traded company holding more than 20% of the European market share and 7% of the worldwide contrast media market.The Guerbet product portfolio is marketed in 130 countries worldwide and contains contrast agen...

TGR BioSciences Pty Ltd

We have a particular interest in gut and skin disorders where products can be delivered locally by ingestion or by topical application. Where possible, we take these products to market as dietary supplements, medical foods or skin care products because the time and cost to market is much less than with drugs.Our products include novel milk-derived bioactive extracts as ingredients for cosmetic and...

Alzheimer's Research and Prevention Foundation

The Alzheimer's Research and Prevention Foundation (ARPF) is a non-profit organization dedicated to reducing the incidence of Alzheimer's disease by conducting clinical research and providing educational outreach about the lifestyle changes that can help prevent Alzheimer's disease. For more information, please visit the Alzheimer's Research and Prevention Foundation at www.alzheimersprevention.o...

Exicure, Inc.

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Exicure’s 3-dimensional, spherical nucleic acid (SNA™) architecture seeks to unlock the potential of nucleic acid therapeutics in multiple organs. Exicure’s lead programs address diseases from ...

The National Action Alliance for Suicide Prevention

The National Action Alliance for Suicide Prevention, a public-private partnership, provides an operating structure to catalyze planning, execution and accountability for updating and advancing the National Strategy for Suicide Prevention. The Alliance's work will generate advancements for practitioners, policymakers, service providers, communities, families, agencies and other partners that play ...

Bartek Ingredients Inc.

Established in 1969, Bartek Ingredients Inc. is a leading producer of malic acid, fumaric acid, and maleic anhydride. Headquartered in Stoney Creek, Ontario, Canada, Bartek employs 115 people across its two production facilities in Southern Ontario. Bartek’s facilities are registered to the ISO 9001:2015 Standard, and it distributes to more than 35 co...

Neviah Genomics

Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Ventures’ Israel Bioincubator and is focused on identifying and developing novel biomarkers for the prediction of drug-induced toxicity. MS Ventures’ Israel BioIncubator provided the initia...

Cancer Prevention Institute of California

The Cancer Prevention Institute of California (CPIC) is the nation's premier organization dedicated to preventing cancer and to reducing its burden where it cannot yet be prevented. Formerly known as the Northern California Cancer Center, CPIC tracks patterns of cancer throughout the entire population and identifies those at risk for developing cancer. Its research scientists are leaders in inves...


More From BioPortfolio on "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks